Cigna Investments Inc. New decreased its position in shares of Express Scripts Holding Company (NASDAQ:ESRX) by 7.6% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 23,439 shares of the company’s stock after selling 1,926 shares during the period. Cigna Investments Inc. New’s holdings in Express Scripts Holding were worth $1,496,000 as of its most recent filing with the SEC.

Other large investors also recently modified their holdings of the company. YCG LLC raised its stake in Express Scripts Holding by 28.9% in the first quarter. YCG LLC now owns 210,813 shares of the company’s stock valued at $13,895,000 after buying an additional 47,272 shares during the last quarter. Old Mutual Global Investors UK Ltd. raised its stake in Express Scripts Holding by 311.4% in the first quarter. Old Mutual Global Investors UK Ltd. now owns 2,157,210 shares of the company’s stock valued at $142,181,000 after buying an additional 1,632,801 shares during the last quarter. Meyer Handelman Co. raised its stake in Express Scripts Holding by 1.8% in the first quarter. Meyer Handelman Co. now owns 12,833 shares of the company’s stock valued at $846,000 after buying an additional 233 shares during the last quarter. Dillon & Associates Inc. raised its stake in Express Scripts Holding by 5.6% in the first quarter. Dillon & Associates Inc. now owns 6,735 shares of the company’s stock valued at $445,000 after buying an additional 355 shares during the last quarter. Finally, Oakworth Capital Inc. raised its stake in Express Scripts Holding by 7.0% in the first quarter. Oakworth Capital Inc. now owns 2,362 shares of the company’s stock valued at $155,000 after buying an additional 155 shares during the last quarter. 88.70% of the stock is owned by institutional investors.

Express Scripts Holding Company (ESRX) opened at 62.16 on Friday. The company has a market cap of $35.90 billion, a P/E ratio of 10.79 and a beta of 0.88. Express Scripts Holding Company has a 12-month low of $57.80 and a 12-month high of $77.50. The stock’s 50 day moving average is $61.87 and its 200 day moving average is $63.73.

Express Scripts Holding (NASDAQ:ESRX) last posted its earnings results on Tuesday, July 25th. The company reported $1.73 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.71 by $0.02. The company had revenue of $25.35 billion during the quarter, compared to analysts’ expectations of $25.52 billion. Express Scripts Holding had a net margin of 3.50% and a return on equity of 25.58%. Express Scripts Holding’s quarterly revenue was up .5% compared to the same quarter last year. During the same quarter last year, the company posted $1.57 EPS. On average, equities analysts forecast that Express Scripts Holding Company will post $6.99 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: “Cigna Investments Inc. New Reduces Position in Express Scripts Holding Company (ESRX)” was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this news story on another domain, it was illegally stolen and reposted in violation of U.S. and international trademark and copyright law. The original version of this news story can be read at https://www.thecerbatgem.com/2017/09/02/cigna-investments-inc-new-reduces-position-in-express-scripts-holding-company-esrx.html.

ESRX has been the subject of several analyst reports. ValuEngine lowered shares of Express Scripts Holding from a “buy” rating to a “hold” rating in a research note on Friday, June 2nd. Jefferies Group LLC set a $72.00 price objective on shares of Express Scripts Holding and gave the company a “buy” rating in a research note on Tuesday. Needham & Company LLC initiated coverage on shares of Express Scripts Holding in a research note on Friday, July 21st. They issued a “hold” rating for the company. Cowen and Company reaffirmed an “outperform” rating and issued a $83.00 price objective on shares of Express Scripts Holding in a research note on Friday, June 9th. Finally, BidaskClub lowered shares of Express Scripts Holding from a “hold” rating to a “sell” rating in a research note on Wednesday, July 12th. Four analysts have rated the stock with a sell rating, thirteen have given a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average price target of $70.24.

In other news, VP Everett Neville sold 1,163 shares of the firm’s stock in a transaction dated Wednesday, August 23rd. The shares were sold at an average price of $61.48, for a total transaction of $71,501.24. Following the completion of the sale, the vice president now owns 18,232 shares in the company, valued at approximately $1,120,903.36. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Company insiders own 0.68% of the company’s stock.

About Express Scripts Holding

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Company (NASDAQ:ESRX).

Institutional Ownership by Quarter for Express Scripts Holding (NASDAQ:ESRX)

Receive News & Stock Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related stocks with our FREE daily email newsletter.